The effects of chicory supplementation on liver enzymes and lipid profiles in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of clinical evidence.

Mehdi Pasalar, Elham Maleki, Ali Sadeghpour, Erfan Taherifard, Bahareh Izadi, Maryam Akbari

Journal: Clinical nutrition ESPEN 2023;55():447-454

PMID: 37202083

Full Text on Elsevier Science View on PubMed

Abstract

BACKGROUND & AIMS

The beneficial effects of Cichorium intybus L., chicory, in patients with non-alcoholic fatty liver disease (NAFLD) are controversial. This review aimed to systematically summarize the evidence on the effects of chicory on liver function and lipid profile in patients with NAFLD.

METHODS

Online databases of Scopus, Web of Science, PubMed, EMBASE, Cochrane Library, and grey literature were searched for relevant randomized clinical trials. Weighted mean differences (WMD) with 95% confidence intervals (CIs) were used as effect sizes and a random-effects model was used to pool the data. Besides, sensitivity analyses and publication bias analysis were performed.

RESULTS

In total, five articles containing 197 patients with NAFLD were included. The study showed that chicory significantly decreased the levels of both aspartate transaminase (WMD: -7.07 U/L, 95%CI: -13.82 to -0.32) and alanine transaminase (WMD: -17.53 U/L, 95%CI: -32.64 to -2.42). However, no significant effects on alkaline phosphatase and gamma-glutamyl transferase levels and the components of the lipid profile were observed with the use of chicory.

CONCLUSIONS

This meta-analysis showed that chicory supplementation may exert potential hepatoprotective effects in patients with NAFLD. However, for widespread recommendations, more studies with a higher number of patients and longer periods of intervention are mandatory.

Address: Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran; Shiraz School for Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.; Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: [email protected].

DOI: 10.1016/j.clnesp.2023.04.025

Link outs

Free resources

Medical:

https://medlineplus.gov/fattyliverdisease.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Humans, Non-alcoholic Fatty Liver Disease, Cichorium intybus, Alanine Transaminase, Lipids, Dietary Supplements